相关实验视频

Updated: Jul 19, 2026

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

腺相关病毒 2 CRISPR/Cas9介导的向乙型肝炎病毒在树中

Md Haroon Or Rashid¹, Mohammad Enamul Hoque Kayesh², Md Abul Hashem³

¹Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.

|February 23, 2025

概括

携带WJ11/Cas9载体的腺相关病毒2 (AAV2) 载体在树中有效抑制了乙型肝炎病毒 (HBV) 复制. 这种新型基因治疗方法减少了病毒DNA和抗原,为慢性HBV感染提供了潜在的新疗法.

科学领域:

肝病学肝病学是一种肝病学.
病毒学病毒学
基因治疗基因治疗

背景情况:

慢性乙型肝炎病毒 (HBV) 感染仍然是一个全球性健康挑战,原因是持续的病毒cccDNA.
目前的治疗方法在完全根除HBV方面存在局限性.
以前的研究表明,AAV2/WJ11-Cas9抑制了HBV复制在体外和小鼠模型中.

研究的目的:

评估AAV2/WJ11-Cas9在一个免疫能力较强的北方树模型中具有急性HBV基因型F感染的疗效.
评估这种基因治疗对病毒载荷,肝脏病理和宿主免疫反应的影响.

主要方法:

北方树被HBV基因型F感染.
治疗涉及AAV2载体介导的WJ11/Cas9.9的输送.
分析了病毒载量 (HBV DNA,cccDNA),病毒抗原 (HBcAg,HBeAg,HBsAg),肝脏组织学和免疫标记物 (细胞因子,TLR,抗体).

主要成果:

AAV2/WJ11-Cas9从感染后1至14天显著降低了血清HBV病毒载量.
治疗减少了肝脏组织中的HBVDNA和ccccDNA,并抑制了病毒抗原.
组织学分析显示,治疗动物的肝细胞损伤和炎症减少.
观察到抑制炎症性细胞因子和托尔类受体 (TLRs).
检测到抗HBc,抗HBs和抗AAV抗体的产生.

结论:

在一个具有免疫能力的树模型中,AAV2 / WJ11-Cas9有效地抑制HBV-F复制和致病性.
这种基因治疗方法显示出治疗慢性HBV感染的潜力.
进一步的翻译研究是有必要的,以适用于人类.

关键词:

腺相关病毒 2 在HBV-F,CRISPR/Cas9的研究中.乙型肝炎病毒的感染.北方树是北方的树.图帕亚亚是什么意思图帕亚是什么意思

更多相关视频

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

相关概念视频

The Antiviral System of Bacteria and Archaea: CRISPR

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this defense.

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...